Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...

Amgen (AMGN) and Kyowa Kirin (KYKOF) announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing therapy targeting ...

(RTTNews) - Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

It was the first time in the postwar era that scholars have been allowed to step foot on the sacred site. The structure itself is 486 meters long and surrounded by a moat, so the group had to ...

Over $1,000,000 in scholarship funds are awarded to 300+ students annually. The ACS Scholars Program awards renewable scholarships to undergraduate students from historically underrepresented groups ...

Pre-Market: 8:33:11 a.m. EDT Loading Chart for AMGN ...